VSee Health, Inc. VSEE
$0.01
$0.00-7.69%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 21.48% | 8.43% | -2.51% | 22.83% | 50.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.48% | 8.43% | -2.51% | 22.83% | 50.38% |
| Cost of Revenue | 136.57% | 72.30% | 48.79% | 78.07% | 24.76% |
| Gross Profit | -26.55% | -22.26% | -25.70% | 1.04% | 64.47% |
| SG&A Expenses | 6.46% | 6.47% | 17.47% | 77.31% | 166.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.08% | 19.53% | 24.20% | 77.48% | 124.25% |
| Operating Income | -36.62% | -36.98% | -83.65% | -291.89% | -516.59% |
| Income Before Tax | 80.15% | 82.19% | 77.05% | 84.07% | -2,063.29% |
| Income Tax Expenses | 9.86% | 104.62% | 103.99% | -94.49% | -90.20% |
| Earnings from Continuing Operations | 80.08% | 81.59% | 76.29% | 84.20% | -1,736.75% |
| Earnings from Discontinued Operations | 351.65% | -538.74% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.47% | 78.37% | 74.50% | 82.42% | -1,742.04% |
| EBIT | -36.62% | -36.98% | -83.65% | -291.89% | -516.59% |
| EBITDA | -58.09% | -39.63% | -79.12% | -288.15% | -294.23% |
| EPS Basic | 92.69% | 88.39% | 82.75% | 84.28% | -959.07% |
| Normalized Basic EPS | -31.60% | 26.36% | -89.41% | -232.36% | 40.47% |
| EPS Diluted | 92.56% | 88.29% | 82.66% | 84.19% | -950.79% |
| Normalized Diluted EPS | -30.77% | 26.36% | -89.41% | -232.36% | 40.47% |
| Average Basic Shares Outstanding | 136.42% | 115.57% | 97.39% | 85.86% | 112.47% |
| Average Diluted Shares Outstanding | 139.76% | 115.57% | 97.39% | 85.86% | 112.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |